Jan Olaf Stracke

2.4k total citations · 1 hit paper
26 papers, 1.8k citations indexed

About

Jan Olaf Stracke is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Jan Olaf Stracke has authored 26 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Immunology. Recurrent topics in Jan Olaf Stracke's work include Protein purification and stability (14 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Glycosylation and Glycoproteins Research (4 papers). Jan Olaf Stracke is often cited by papers focused on Protein purification and stability (14 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Glycosylation and Glycoproteins Research (4 papers). Jan Olaf Stracke collaborates with scholars based in Switzerland, Germany and United Kingdom. Jan Olaf Stracke's co-authors include Gillian Murphy, Vera Knäuper, Petra Rueger, Wilma Lau, Bernd Moritz, Mike Hutton, William English, Jens Niewoehner, Anirvan Ghosh and Bernd Bohrmann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Neuron.

In The Last Decade

Jan Olaf Stracke

26 papers receiving 1.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle

2014 438 citations Jens Niewoehner, Bernd Bohrmann et al. Neuron profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Olaf Stracke Switzerland	18	1.0k	728	355	351	268	26	1.8k
Ricardo F. Frausto United States	23	1.3k 1.3×	492 0.7×	291 0.8×	340 1.0×	374 1.4×	49	2.6k
Stéphanie Filleur United States	23	1.3k 1.3×	202 0.3×	769 2.2×	555 1.6×	259 1.0×	45	2.3k
Deric M. Park United States	26	861 0.9×	119 0.2×	543 1.5×	490 1.4×	311 1.2×	54	2.1k
Bryan Knuckley United States	20	974 1.0×	243 0.3×	487 1.4×	237 0.7×	711 2.7×	32	1.9k
Martin Lenter Germany	26	1.6k 1.6×	222 0.3×	879 2.5×	564 1.6×	599 2.2×	44	3.1k
Nozomi Yamaguchi Japan	27	905 0.9×	162 0.2×	377 1.1×	303 0.9×	262 1.0×	71	2.2k
Antonella Zannetti Italy	27	1.1k 1.0×	278 0.4×	669 1.9×	426 1.2×	240 0.9×	66	2.0k
David J. Sieg United States	9	1.8k 1.8×	219 0.3×	578 1.6×	591 1.7×	408 1.5×	10	3.7k
Wai Lee Wong United States	23	1.5k 1.5×	1.7k 2.4×	1.6k 4.6×	138 0.4×	375 1.4×	39	3.3k
Elisabeth Génot France	31	1.5k 1.5×	102 0.1×	614 1.7×	498 1.4×	594 2.2×	87	3.1k

Countries citing papers authored by Jan Olaf Stracke

Since Specialization

Citations

This map shows the geographic impact of Jan Olaf Stracke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Olaf Stracke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Olaf Stracke more than expected).

Fields of papers citing papers by Jan Olaf Stracke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Olaf Stracke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Olaf Stracke. The network helps show where Jan Olaf Stracke may publish in the future.

Co-authorship network of co-authors of Jan Olaf Stracke

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Olaf Stracke. A scholar is included among the top collaborators of Jan Olaf Stracke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Olaf Stracke. Jan Olaf Stracke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Germershaus, Oliver, et al.. (2024). Comparison of Protein-like Model Particles Fabricated by Micro 3D Printing to Established Standard Particles. Journal of Pharmaceutical Sciences. 113(8). 2394–2404. 1 indexed citations

Chen, Wei, Denis Klemm, Ravuri S. K. Kishore, et al.. (2023). Screening techniques for monitoring the sub-visible particle formation of free fatty acids in biopharmaceuticals. European Journal of Pharmaceutics and Biopharmaceutics. 190. 242–247. 4 indexed citations

Winter, Martin, Franziska Zähringer, Tarik A. Khan, et al.. (2023). Identification of Hetero-aggregates in Antibody Co-formulations by Multi-dimensional Liquid Chromatography Coupled to Mass Spectrometry. Analytical Chemistry. 95(4). 2203–2212. 11 indexed citations

Kiessig, Steffen, et al.. (2021). Quantifying methionine sulfoxide in therapeutic protein formulation excipients as sensitive oxidation marker. Journal of Chromatography B. 1189. 123092–123092. 6 indexed citations

Kiessig, Steffen, et al.. (2019). Application of affinity capillary electrophoresis for charge heterogeneity profiling of biopharmaceuticals. Electrophoresis. 40(22). 3014–3022. 12 indexed citations

Stracke, Jan Olaf, Stefan Dengl, Alexander Knaupp, et al.. (2016). Oxidation in the complementarity-determining regions differentially influences the properties of therapeutic antibodies. mAbs. 8(8). 1525–1535. 44 indexed citations

Patel, Sulabh, Jan Olaf Stracke, Hanns‐Christian Mahler, et al.. (2016). Prediction of intraocular antibody drug stability using ex-vivo ocular model. European Journal of Pharmaceutics and Biopharmaceutics. 112. 177–186. 12 indexed citations

Bauss, Frieder, Martin Lechmann, Ben‐Fillippo Krippendorff, et al.. (2016). Characterization of a re‐engineered, mesothelin‐targetedPseudomonasexotoxin fusion protein for lung cancer therapy. Molecular Oncology. 10(8). 1317–1329. 48 indexed citations

Ringler, Philippe, Alexandra Graff-Meyer, Henning Stahlberg, et al.. (2016). Characterization of mAb dimers reveals predominant dimer forms common in therapeutic mAbs. mAbs. 8(5). 928–940. 38 indexed citations

10.

Moritz, Bernd & Jan Olaf Stracke. (2016). Assessment of disulfide and hinge modifications in monoclonal antibodies. Electrophoresis. 38(6). 769–785. 66 indexed citations

11.

Patel, Sulabh, et al.. (2015). Evaluation of protein drug stability with vitreous humor in a novel ex-vivo intraocular model. European Journal of Pharmaceutics and Biopharmaceutics. 95(Pt B). 407–417. 25 indexed citations

12.

Niewoehner, Jens, Bernd Bohrmann, Ludovic Collin, et al.. (2014). Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle. Neuron. 81(1). 49–60. 438 indexed citations breakdown →

13.

Stracke, Jan Olaf, Thomas Emrich, Petra Rueger, et al.. (2014). A novel approach to investigate the effect of methionine oxidation on pharmacokinetic properties of therapeutic antibodies. mAbs. 6(5). 1229–1242. 93 indexed citations

14.

Wartha, Katharina, Rebecca Croasdale, Samuel Moser, et al.. (2014). A Novel Glycoengineered Bispecific Antibody Format for Targeted Inhibition of Epidermal Growth Factor Receptor (EGFR) and Insulin-like Growth Factor Receptor Type I (IGF-1R) Demonstrating Unique Molecular Properties. Journal of Biological Chemistry. 289(27). 18693–18706. 45 indexed citations

15.

Schlothauer, Tilman, Petra Rueger, Jan Olaf Stracke, et al.. (2013). Analytical FcRn affinity chromatography for functional characterization of monoclonal antibodies. mAbs. 5(4). 576–586. 111 indexed citations

16.

Diepold, Katharina, Boris Zimmermann, A. Petzold, et al.. (2012). Simultaneous Assessment of Asp Isomerization and Asn Deamidation in Recombinant Antibodies by LC-MS following Incubation at Elevated Temperatures. PLoS ONE. 7(1). e30295–e30295. 95 indexed citations

17.

Schanzer, Jürgen, Andreas Jekle, Jun‐ichi Nezu, et al.. (2011). Development of Tetravalent, Bispecific CCR5 Antibodies with Antiviral Activity against CCR5 Monoclonal Antibody-Resistant HIV-1 Strains. Antimicrobial Agents and Chemotherapy. 55(5). 2369–2378. 53 indexed citations

18.

English, William, Gloria Velasco, Jan Olaf Stracke, Vera Knäuper, & Gillian Murphy. (2001). Catalytic activities of membrane‐type 6 matrix metalloproteinase (MMP25). FEBS Letters. 491(1-2). 137–142. 75 indexed citations

19.

Stracke, Jan Olaf, Mike Hutton, Margaret L. Stewart, et al.. (2000). Biochemical Characterization of the Catalytic Domain of Human Matrix Metalloproteinase 19. Journal of Biological Chemistry. 275(20). 14809–14816. 118 indexed citations

20.

Stracke, Jan Olaf, Amanda Fosang, Karena Last, et al.. (2000). Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP). FEBS Letters. 478(1-2). 52–56. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact